Premium
Pemphigus vulgaris precipitated by glibenclamide therapy
Author(s) -
Paterson A. J.,
Lamey PJ.,
Lewis M. A. O.,
Nolan A.,
Rademaker M.
Publication year - 1993
Publication title -
journal of oral pathology and medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.887
H-Index - 83
eISSN - 1600-0714
pISSN - 0904-2512
DOI - 10.1111/j.1600-0714.1993.tb00051.x
Subject(s) - pemphigus vulgaris , glibenclamide , dermatology , medicine , pemphigus , endocrinology , diabetes mellitus
Pemphigus vulgaris (PV) is a rare but potentially fatal autoimmune bullous disorder which frequently affects the oral mucosa. Although the essential cause of PV is unclear, its onset has occasionally been associated with drug therapy, in particular penicillamine. The patient described in this paper was a 78‐year‐old diabetic man who developed oral lesions of PV following institution of glibenclamide therapy.